Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia – a novel fumarylacetoacetate hydrolase (FAH) intronic disease-causing variant
ID
Šikonja, Jaka
(
Author
),
ID
Brecelj, Jernej
(
Author
),
ID
Žerjav-Tanšek, Mojca
(
Author
),
ID
Repič-Lampret, Barbka
(
Author
),
ID
Drole Torkar, Ana
(
Author
),
ID
Klemenčič, Simona
(
Author
),
ID
Lipovec, Neža
(
Author
),
ID
Stefanova Kralj, Valentina
(
Author
),
ID
Bertok, Sara
(
Author
),
ID
Kovač, Jernej
(
Author
),
ID
Faganel Kotnik, Barbara
(
Author
),
ID
Tesařová, Markéta
(
Author
),
ID
Remec, Žiga Iztok
(
Author
),
ID
Debeljak, Maruša
(
Author
),
ID
Battelino, Tadej
(
Author
),
ID
Grošelj, Urh
(
Author
)
PDF - Presentation file,
Download
(1,10 MB)
MD5: 89885C12E64228FAE0D4B659B70830CC
URL - Source URL, Visit
https://www.sciencedirect.com/science/article/pii/S2214426921001312
Image galllery
Abstract
Tyrosinemia type 1 (HT1) is an inborn error of tyrosine catabolism that leads to severe liver, kidney, and neurological dysfunction. Newborn screening (NBS) can enable a timely diagnosis and early initiation of treatment. We presented the follow up of the only two Slovenian patients diagnosed with HT1. Metabolic control was monitored by measuring tyrosine, phenylalanine and succinylacetone from dried blood spots (DBSs). Retrograde screening of HT1 was performed from DBSs taken at birth using tandem mass spectrometry. First patient was diagnosed at the age of 6 months in the asymptomatic phase due to an abnormal liver echogenicity, the other presented at 2.5 months with an acute liver failure and needed a liver transplantation. The first was a compound heterozygote for a novel FAH intronic variant c.607-21A>G and c.192G>T whereas the second was homozygous for c.192G>T. At the non-transplanted patient, 66% of tyrosine and 79% of phenylalanine measurements were in strict reference ranges of 200–400 μmol/L and >30 μmol/L, respectively, which resulted in a favorable cognitive outcome at 3.6 years. On retrograde screening, both patients had elevated SA levels; on the other hand, tyrosine was elevated only at one. We showed that non-coding regions should be analyzed when clinical and biochemical markers are characteristic of HT1. DBSs represent a convenient sample type for frequent amino acid monitoring. Retrograde diagnosis of HT1 was possible after more than three years of birth with SA as a primary marker, complemented by tyrosine.
Language:
English
Keywords:
tyrosinemia
,
fumarylacetoacetate hydrolase
,
nitisinone
,
dried blood spot
,
succinylacetone
,
intronic variant
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
7 str.
Numbering:
Vol. 30, art. 100836
PID:
20.500.12556/RUL-138896
UDC:
616-053.2:577.122.5
ISSN on article:
2214-4269
DOI:
10.1016/j.ymgmr.2021.100836
COBISS.SI-ID:
90521859
Publication date in RUL:
24.08.2022
Views:
676
Downloads:
143
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Molecular genetics and metabolism reports
Publisher:
Elsevier
ISSN:
2214-4269
COBISS.SI-ID:
520387097
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
pediatrija
,
tirozenemija
,
presejalno testiranje
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0343
Name:
Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih
Funder:
ARRS - Slovenian Research Agency
Project number:
J4-3606
Name:
Vloga humanega mleka v razvoju črevesne mikrobiote dojenčka
Funder:
ARRS - Slovenian Research Agency
Project number:
L3-8213
Name:
Prehrana otrok in odraslih kot zaščitni dejavnik ali dejavnik zdravstvenih tveganj
Funder:
ARRS - Slovenian Research Agency
Project number:
L3-7538
Name:
Transmaščobe v živilih in njihov populacijski vnos - implikacije za javno zdravje
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0395
Name:
Prehrana in javno zdravje
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back